CSF2 and myeloid sarcoma: In clinical studies involving MS patients, the relative distribution of IFN-γ+GM-CSF+ versus IL-17+GM-CSF+ Th cells varies significantly across cohorts, indicating heterogeneity in the GM-CSF+ Th cell compartment among individuals.